On January 3, 2019 Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, reported that its Chief Executive Officer, Nancy Simonian, M.D., will present a corporate overview, including 2019 objectives, at the 37th Annual J.P. Morgan Healthcare Conference. Details are as follows (Press release, Syros Pharmaceuticals, JAN 3, 2019, View Source [SID1234532420]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
37th Annual J.P. Morgan Healthcare Conference
Date: Thursday, January 10
Time: 9:00 a.m. PST (12:00 p.m. EST)
Location: Westin St. Francis Hotel, 335 Powell St., San Francisco, CA
The presentation will be followed by a question and answer session.
Live webcasts of the presentation and question and answer session will be available on the Investors & Media section of the Syros website at www.syros.com. An archived replay of both webcasts will be available for approximately 30 days.